Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

Thursday’s trading has closed, but PTX is being traded in the after-hours session. After-Hours quote »
4.60
Delayed Data
As of 3:59pm ET
 -0.04 / -0.86%
Today’s Change
4.25
Today|||52-Week Range
12.88
-51.01%
Year-to-Date

Today’s Trading

Previous close4.64
Today’s open4.70
Day’s range4.55 - 4.70
Volume682,284
Average volume (3 months)1,258,121
Market cap$283.2M
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-79.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book2.13

Competitors

 Today’s
change
Today’s
% change
CPRXCatalyst Pharmaceuti...+0.20+5.78%
FOMXFoamix Pharmaceutica...+0.42+4.34%
POZNPOZEN Inc+0.43+5.12%
THLDThreshold Pharmaceut...+0.14+3.41%
Data as of 3:59pm ET, 08/27/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

Partner Offers